PUBLISHER: The Business Research Company | PRODUCT CODE: 1942612
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942612
Continuous renal replacement therapy (CRRT) machines are specialized medical devices used to deliver continuous, slow, and controlled dialysis treatment to critically ill patients suffering from acute kidney injury (AKI) or severe fluid overload, typically within an intensive care unit (ICU). Unlike traditional dialysis, which is performed intermittently, CRRT operates continuously over 24 hours, offering a gentler approach for patients who are unstable. These machines assist in managing and replacing the filtration function of the kidneys in critically ill patients whose kidneys are compromised due to acute injury or illness.
The continuous renal replacement therapy machine market includes two main types, mobile and fixed. Mobile CRRT machines are designed for easy transport and use across various hospital units. The different modalities offered by these machines include slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These machines cater to various age groups, including pediatric, adult, and geriatric patients, and are used for applications such as treating acute renal failure, chronic renal failure, and other conditions. End-users of these machines include hospitals, clinics, dialysis centers, home care settings, and more.
Tariffs are impacting the continuous renal replacement therapy machine market by increasing costs for imported electronic components, sensors, hemofilters, and precision-engineered parts used in mobile and fixed crrt machines. These cost pressures have particularly affected high-performance and portable machine segments, with asia-pacific and europe being more exposed due to global manufacturing and sourcing dependencies. Higher tariffs have raised capital equipment costs for hospitals and dialysis centers and influenced procurement timelines. However, tariffs have also encouraged local manufacturing, regional assembly, and supplier diversification, strengthening long-term supply chain resilience.
The continuous renal replacement therapy machine market research report is one of a series of new reports from The Business Research Company that provides continuous renal replacement therapy machine market statistics, including continuous renal replacement therapy machine industry global market size, regional shares, competitors with a continuous renal replacement therapy machine market share, detailed continuous renal replacement therapy machine market segments, market trends and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy machine industry. This continuous renal replacement therapy machine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The continuous renal replacement therapy machine market size has grown strongly in recent years. It will grow from $1.37 billion in 2025 to $1.49 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising incidence of acute kidney injury in icu settings, increasing prevalence of sepsis and multi-organ failure, expansion of critical care infrastructure, growing adoption of continuous renal support therapies, improved survival rates among critically ill patients.
The continuous renal replacement therapy machine market size is expected to see strong growth in the next few years. It will grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to aging population with higher aki risk, increasing demand for gentle renal replacement therapies, rising icu admission rates globally, growing focus on individualized critical care treatment, expansion of advanced critical care facilities in emerging markets. Major trends in the forecast period include rising adoption of crrt machines in intensive care units, increasing demand for continuous dialysis in hemodynamically unstable patients, growing preference for mobile and portable crrt machines, expansion of crrt use across pediatric and geriatric care, increasing focus on precision fluid and solute management.
The increasing incidence of acute kidney injury (AKI) is projected to drive the growth of the continuous renal replacement therapy (CRRT) machine market. AKI is characterized by a sudden loss of kidney function, impairing the kidneys' ability to filter waste and regulate fluid and electrolyte balance. This condition can result from decreased blood flow to the kidneys, direct damage from toxins or infections, or urinary tract obstructions. CRRT machines are designed to provide continuous, gentle dialysis, gradually removing waste products and excess fluids from the blood to stabilize the patient's condition and prevent complications. For example, in June 2023, Kidney Research, a UK-based charity, estimated 615,000 cases of AKI in 2022. The number of cases is expected to rise by 4% to 637,000 by 2033. As a result, the growing prevalence of AKI is boosting the demand for CRRT machines.
Leading companies in the continuous renal replacement therapy (CRRT) machine market are prioritizing technological advancements, including the integration of augmented reality (AR), to improve real-time monitoring and enhance clinical outcomes for patients. The use of AR in CRRT machines is being explored to enhance visualization of patient data, support real-time monitoring, and improve clinical decision-making by overlaying essential information directly into the clinician's view. For example, in March 2024, Fresenius Medical Care, a Germany-based healthcare leader, launched an innovative "Augmented Reality" (AR) training program specifically designed for its Continuous Kidney Replacement Therapy device, the multiFiltrate PRO. This program was introduced at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels.
In September 2025, Quanta Dialysis Technologies Ltd., a UK-based medical technology company, partnered with Innovative Renal Care to expand the availability of advanced dialysis treatments, including CRRT, for patients throughout the United States. This partnership aims to increase access to innovative dialysis solutions, strengthen continuous renal replacement therapy capabilities, and improve patient outcomes in US acute care and hospital settings. Innovative Renal Care is a US-based kidney care company that provides continuous renal replacement therapy.
Major companies operating in the continuous renal replacement therapy machine market are Medtronic plc, Fresenius Medical Care AG KGaA, GE HealthCare Technologies Inc., Baxter International Inc., Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Nipro Corporation, B Braun Medical Inc., Shandong Weigao Blood Purification Products Co Ltd, Nikkiso Co Ltd, JMS Co Ltd, NxStage Medical Inc., Guangdong Biolight Meditech Co Ltd, Quanta Dialysis Technologies Ltd, Medica S.p.A., Anjue Medical Equipment Co Ltd, Infomed SA, SWS Hemodialysis Care Co Ltd, Kawasumi Laboratories Incorporated, Toray Industries Inc
North America was the largest region in the continuous renal replacement therapy machine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy machine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the continuous renal replacement therapy machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The continuous renal replacement therapy machine market consists of sales of blood tubing sets, dialyzers or hemofilters, replacement fluids, anticoagulants, and vascular access catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Continuous Renal Replacement Therapy Machine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses continuous renal replacement therapy machine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for continuous renal replacement therapy machine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous renal replacement therapy machine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.